Physician profile
Michael L Wang
NPI 1861424178
$3,848.42
in general payments reported to CMS, 2019-2025
21 companies · $594 in 2025
The $594 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $214 · 2021: $366 · 2022: $544 · 2023: $895 · 2024: $894 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,382.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,022.89 | 2022-2025 | Durysta, Lumigan, Botox |
| Alcon Vision LLC | $823.85 | 2019-2025 | Hydrus Microstent, Clareon, Voyager Dslt |
| Glaukos Corporation | $293.58 | 2022-2025 | Idosetr, Istent Infinite |
| Oyster Point Pharma, INC. | $276.36 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $265.30 | 2019-2025 | Cequa |
| Sight Sciences, INC. | $225.06 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Novartis Pharmaceuticals Corporation | $182.05 | 2019-2022 | |
| Harrow Eye, LLC | $116.00 | 2024-2025 | Vevye |
| Allergan, INC. | $101.93 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $89.27 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $67.89 | 2022-2024 | Acthar |
| Bausch & Lomb Americas INC. | $66.57 | 2023-2024 | Miebo, Xiidra |
| Thea Pharma INC. | $59.03 | 2024-2025 | Iyuzeh |
| Optos, INC. | $52.47 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $46.37 | 2023-2024 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $36.95 | 2023 | Cirrus Hd-Oct |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.44 | 2020-2021 | |
| Ivantis, INC | $36.09 | 2020 | |
| Kala Pharmaceuticals, INC. | $23.34 | 2021 | |
| Omeros Corporation | $15.52 | 2019 | |
| New World Medical,INC. | $11.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.